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ABSTRACT
CONTEXT AND OBJECTIVE: Controversy exists regarding the site of action of fentanyl after epidural injection. The objective of this investigation was to 
compare the efficacy of epidural and intravenous fentanyl for orthopedic surgery. 
DESIGN AND SETTING: A randomized double-blind study was performed in Hospital São Paulo. 
METHODS: During the postoperative period, in the presence of pain, 29 patients were divided into two groups: group 1 (n = 14) received 100 µg of 
fentanyl epidurally and 2 ml of saline intravenously; group 2 (n = 15) received 5 ml of saline epidurally and 100 µg of fentanyl intravenously. The analgesic 
supplementation consisted of 40 mg of tenoxicam intravenously and, if necessary, 5 ml of 0.25% bupivacaine epidurally. Pain intensity was evaluated on 
a numerical scale and plasma concentrations of fentanyl were measured simultaneously. 
RESULTS: The percentage of patients who required supplementary analgesia with tenoxicam was lower in group 1 (71.4%) than in group 2 (100%): 95% 
confidence interval (CI) = 0.001-0.4360 (P = 0.001, Fisher’s exact test; relative risk, RR = 0.07). Epidural bupivacaine supplementation was also lower 
in group 1 (14.3%) than in group 2 (53.3%): 95% CI = 0.06-1.05 (P = 0.03, Fisher’s exact test; RR = 0.26). There was no difference in pain intensity on 
the numerical scale. Mean fentanyl plasma concentrations were similar in the two groups. 
CONCLUSION: Intravenous and epidural fentanyl appear to have similar efficacy for reducing pain according to the numerical scale, but supplementary 
analgesia was needed less frequently when epidural fentanyl was used.
CLINICAL TRIAL REGISTRATION NUMBER: NCT00635986
RESUMO
CONTEXTO E OBJETIVO: Existem controvérsias sobre o local de ação do fentanil injetado por via peridural. O objetivo foi comparar a eficácia do fentanil 
peridural e do venoso em cirurgias ortopédicas.
TIPO DE ESTUDO E LOCAL: Estudo aleatório, duplo-cego, realizado no Hospital São Paulo. 
MÉTODO: No pós-operatório, na presença de dor, 29 pacientes foram divididos em dois grupos: grupo 1 (n = 14) recebeu solução de 100 mcg de fentanil 
por via peridural e 2 ml de solução salina venosa; grupo 2 (n = 15), 5 ml de solução salina peridural e 100 µg de fentanil venoso. A complementação 
analgésica foi com 40 mg de tenoxicam venoso e, se necessário, 5 ml de bupivacaína 0.25%. A intensidade da dor foi avaliada pela escala numérica e 
a concentração plasmática do fentanil foi medida simultaneamente.
RESULTADOS: A percentagem de pacientes que necessitaram de complementação analgésica com tenoxicam foi menor no grupo 1 (71.4% versus 
100.0% grupo 2): intervalo de confiança, IC 95% = 0.001-0.4360 (P = 0.001, teste exato de Fisher; risco relativo, RR = 0.07). A complementação com 
bupivacaína peridural também foi menor no grupo 1 (14.3% versus 53.3% grupo 2): IC 95% = 0.06-1.05 (P = 0.03, teste exato de Fisher; RR = 0.26). 
Não houve diferença na intensidade da dor avaliada pela escala numérica. As concentrações plasmáticas do fentanil foram semelhantes nos dois 
grupos. 
CONCLUSÃO: A eficácia do fentanil venoso e peridural parece ser semelhante na redução da dor de acordo com a escala numérica, porém a frequência 
de analgesia suplementar foi menor com o uso do fentanil peridural.
REGISTRO DE ENSAIO CLÍNICO: NCT00635986
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INTRODUCTION
The discovery that opioids act by activating receptors located in the 
dorsal horn of the spinal cord, and reports of intense and long-lasting 
pain relief after intrathecal injection of morphine1 have been important 
steps for postoperative analgesia.
Fentanyl is one of the most widely used opioids administered epidu-
rally. The risk of respiratory depression is low and the incidence of side 
effects (itching, nausea, vomiting and urine retention) is lower than that 
observed with morphine.2 Controversy exists regarding the site of action 
of fentanyl after epidural injection. Some authors have suggested that 
its effect is directly mediated in the spinal cord, while others have be-
lieved that the main site of action is the supraspinal region, in view of its 
high liposolubility, with consequent absorption into the systemic circu-
lation and distribution to the brain.3 Other investigators have suggested 
a combination of these two mechanisms to explain the action of epidu-
ral fentanyl.4 Thus, further studies are necessary to explain the sites of 
action of this drug when administered epidurally and also to determine 
whether there is any difference in the analgesic effect between applying 
the drug intravenously and epidurally.
OBJECTIVE
To evaluate the efficacy of fentanyl (100 µg) administered by the 
epidural or intravenous routes after lower-limb orthopedic surgery, tak-
ing the primary outcome to be pain and the secondary outcome to be 
the requirement for supplementary analgesia during the postoperative 
period.
METHODS
Twenty-nine consecutive patients admitted during a one-year pe-
riod (from February 2005 to January 2006), of both genders and rang-
ing in age from 18 to 65 years, were studied. They were all classified as 
presenting American Society of Anesthesiologists (ASA) physical status 
1 or 2 and had been scheduled for orthopedic bone surgery on the low-
er limbs. The study was approved by the Ethics Committee of Hospital 
São Paulo, Medical School, Universidade Federal de São Paulo — Esco-
la Paulista de Medicina (Unifesp-EPM), and written informed consent 
was obtained from all patients.
Patients with infection in the puncture area, those with coagulation 
disorders, pregnant patients, and patients using opioids were excluded 
from the study.
The study was conducted in a double-blind manner and each pa-
tient was randomly assigned to one of two groups. The process of ran-
domization consisted of drawing lots for the procedures, which were 
kept in sealed envelopes. The draw was performed by a single phy-
sician who prepared the medication. Another physician was respon-
sible for injection of the epidural and venous medication, while the 
researcher was responsible for evaluation of the patients. Both physi-
cians and the patients were unaware of the group chosen by lot until 
the end of the study. 
The medications were prepared in the same volumes and solution 
colors for the two groups. Thus, both the physician responsible for the 
procedure and the researcher were unaware of the group to which the 
patient belonged.
The epidural anesthesia consisted of 20 ml of 0.5% bupivacaine to-
gether with epinephrine (1:200,000), injected between L3-L4 and L4-
L5 and supplemented with 5 ml of bupivacaine when necessary. After 
injection, an epidural catheter was inserted for postoperative analgesia. 
Sedation was achieved using 2-5 mg of midazolam. 
During the postoperative period, when the patient complained of 
pain, the group 1 patients (n = 14) received 5 ml of a solution contain-
ing 100 µg of fentanyl diluted in saline epidurally and 2 ml of saline in-
travenously. The group 2 patients (n = 15) received 5 ml of saline epi-
durally and 2 ml of fentanyl (100 µg) intravenously. Thus, the patients 
of both groups received both an intravenous and an epidural solution, 
thus ensuring double-blind study conditions, i.e. group 1: epidural fen-
tanyl + intravenous saline (placebo); group 2: epidural saline (placebo) 
+ intravenous fentanyl.
If supplementation was necessary, 40 mg of tenoxicam was admin-
istered intravenously, and if the patient continued to complain of pain, 
5 ml of 0.25% bupivacaine was injected. 
The pain intensity was evaluated 30 minutes, two hours and four 
hours after injection of fentanyl, on a scale ranging from 0 (no pain) to 
ten (very intense pain).5,6 On the same occasions, venous blood sam-
ples were collected for measurement of plasma fentanyl concentrations. 
The blood samples were immediately centrifuged and the plasma was 
separated and stored at -70 °C until the time for spectrochromatogra-
phy analysis. The quantification limit of the method was 0.05 ng/ml of 
plasma.
Thirty patients were originally selected (15 per group), but one pa-
tient in group 1 was excluded from the study because blood entered the 
epidural catheter.
For statistical analysis, the distribution of frequency data was ana-
lyzed by means of the chi-square test using the GraphPad InStat soft-
ware. Two-way repeated-measurement analysis of variance (ANOVA) 
was used to compare the samples, repeated over time. Student’s t test, 
Fisher’s exact test, and Mann Whitney test were also applied. 
Our hypothesis was that intravenous fentanyl was associated with 
a response rate of 30%. Assuming that epidural fentanyl would have a 
response rate of 80% improvement in pain response (primary outcome) 
and considering a power of 95% (beta) and P = 0.05% (alpha), the sam-
ple size would be 15.54. 
RESULTS
There were no significant differences between the groups with re-
gard to gender, age, weight, height or body mass index (Table 1). In 
addition, no significant difference in the duration of surgery was ob-
served between the groups (137 minutes for group 1 and 135 minutes 
for group 2). The interval between the beginning of anesthesia and the 
administration of epidural fentanyl (group 1) was 380 ± 101 minutes, 
and the interval between the beginning of anesthesia and the adminis-
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Gender
(F, M)
Age
(years)
Weight
(kg)
Height
(cm)
BMI
(kg/m2)
Group 1 (n = 14) 3F; 11 M 35.28 ± 15.68 71.14 ± 11.79 170.93 ± 8.27 24.42 ± 4.12
Group 2 (n = 15) 5F; 10 M 41.26 ± 13.24 74.73  ± 9.25 167.87 ± 8.32 26.52 ± 2.46
P 0.6817 0.27621 0.36321 0.50151 0.16281
Table 1. Demographic data on the patients
Group 1 = epidural fentanyl; Group 2 = intravenous fentanyl; P = statistical significance, ≤ 0.05; M = male; F = female; BMI = body mass index; p = Fisher’s exact test; P1 = Student’s t test; values expressed as mean ± standard 
deviation.
tration of intravenous fentanyl (group 2) was 331 ± 83 minutes, with no 
significant difference between the groups (Student’s t test, P = 0.17).
The percentage of patients who required supplementary anal-
gesia with tenoxicam was lower in group 1 (71.4%) than in group 2 
(100.0%): 95% confidence interval (CI) = 0.001-0.4360 (Fisher’s exact 
test, P = 0.04; risk relative, RR = 0.07). Epidural bupivacaine supple-
mentation was also lower in group 1 (14.3%) than in group 2 (53.3%): 
95% CI = 0.06-1.05 (Fisher’s exact test, P = 0.05; RR = 0.26). The first 
analgesic supplementation was necessary after 125.7 ± 57.6 minutes in 
group 1 and after 98.3 ± 49.5 minutes in group 2, without any signifi-
cant difference (Mann-Whitney test, P = 0.267). No significant differ-
ence in pain intensity evaluated on the numerical scale was observed be-
tween the groups (Table 2).
The mean plasma fentanyl concentrations (ng/ml) were similar in 
the two groups (ANOVA, P = 0.67; Table 3). Tables 4, 5 and 6 show 
the cumulative numbers and percentages of patients who had required 
supplementary analgesics up to the time of each evaluation (T0, T30, T120 
and T240), as well as the mean pain intensity and plasma fentanyl con-
centrations at these times. 
In group 1, at T30, the mean pain intensity among the patients who 
did not require supplementary analgesics (n = 13; 93%) was 0.2 and the 
plasma fentanyl concentration was 0.20 ng/ml. The single patient (7%) 
who received tenoxicam had a pain intensity score of 3 and a plasma 
fentanyl concentration of 0.27 ng/ml. At T120, the mean pain intensity 
among the patients who still had not required analgesic supplements 
(n = 7; 50%) was 0.3 and the plasma fentanyl concentration was 0.23 
ng/ml. For the patients who received tenoxicam (n = 7; 50%), the pain 
intensity score was 3.9 and the mean plasma fentanyl concentration was 
0.23 ng/ml. The single patient (7%) who received bupivacaine present-
ed a pain intensity score of 10 and a plasma fentanyl concentration of 
0.26 ng/ml. At T240, the mean pain intensity among the patients who 
had not required analgesic supplements until that time (n = 4; 29%) was 
2.2 and the plasma fentanyl concentration was 0.55 ng/ml. The pain in-
tensity score of the patients who received tenoxicam (n = 10; 71%) was 
2.4 and the plasma fentanyl concentration was 0.19 ng/ml. For the pa-
tients who received bupivacaine (n = 2; 14%), the pain intensity score 
was 2.5 and the plasma fentanyl concentration was 0.16 ng/ml. 
In group 2, at T30, the mean pain intensity among the patients who 
did not require tenoxicam supplementation (n = 15; 100%) was 0.9 and 
the plasma fentanyl concentration was 0.31 ng/ml. At T120, the pain in-
tensity among the patients who did not require analgesic supplements 
(n = 3; 20%) was 3.4 and the plasma fentanyl concentration was 0.21 
ng/ml. The pain intensity among the patients who received tenoxicam 
(n = 12; 80%) was 4 and the plasma fentanyl concentration was 0.20 
ng/ml. For the patients who received bupivacaine (n = 3; 20%), the pain 
intensity score was 2 and the plasma fentanyl concentration was 0.24 
ng/ml. At T240, all the patients had received tenoxicam supplementa-
tion, and these patients (n = 15; 100%) presented a pain intensity score 
of 2.5 and a plasma fentanyl concentration of 0.16 ng/ml. The pain 
intensity among the patients who had received bupivacaine up to that 
time (n = 8; 54%) was 0.6 and the plasma fentanyl concentration was 
0.19 ng/ml.
The side effects observed were nausea (group 1: one patient; group 
2: one patient), vomiting (group 2: one patient), and urine retention 
(group 2: two patients). 
DISCUSSION
Several investigators7-20 have evaluated the mechanism of action of 
fentanyl administered epidurally. Although many studies3,9-12,15,17 have 
concluded that the mechanism of action is associated with systemic 
absorption of the opioid into the circulation, followed by a supraspi-
nal effect, many investigators continue to use fentanyl as a continuous 
infusion. According to the literature,2,9 with continuous infusion, the 
higher plasma concentration of fentanyl promotes supraspinal action. 
In these studies, the plasma fentanyl concentrations were around 0.63 
ng/ml for patients to maintain pain relief. We used a single bolus of 
epidural fentanyl.
Time (minutes)
P1
T30 T120 T240
Group 1 (n = 14) 0.35 ± 0.22 2.07 ± 0.86 2.35 ± 0.65 0.0112
95% CI - 0.13 - 0.84 0.21 - 3.93 0.95 - 3.76
Group 2 (n = 15) 0.86 ± 0.43 3.60 ± 0.70 2.46 ± 0.80 0.0101
95% CI - 0.06 - 1.80 2.09 - 5.10 0.73 - 4.20
P2 0.7013 0.0843 0.8794
Table 2. Pain intensity at each evaluation time (mean ± standard error of 
the mean)
Group 1 = epidural fentanyl; Group 2 = intravenous fentanyl; T30; T120; T240 = times (min) after the administration 
of fentanyl; 95% CI = 95% confidence interval; P1 = analysis of variance (ANOVA); P2 = Student’s t test. 
Time (min)
P1
T30 T120 T240
Group 1 (n = 14) 0.21 ± 0.06 0.23 ± 0.15 0.29 ± 0.41 0.6642
95% CI 0.17 - 0.24 0.15 - 0.32 0.06 - 0.53
Group 2 (n = 15) 0.31 ± 0.16 0.21 ± 0.10 0.16 ± 0.08 0.0008
95% CI 0.22 - 0.39 0.15 - 0.26 0.11 - 0.21
P2 0.0734 0.9304 0.3480
Table 3. Fentanyl plasma concentrations (ng/ml)
Group 1 = epidural fentanyl; Group 2 = intravenous fentanyl; T30; T120; T240: times (min) after the administration 
of fentanyl; 95% CI = 95% confidence interval; P1 = analysis of variance (ANOVA); P2 = Student’s t test.
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Although methods for measuring plasma fentanyl concentrations 
are available, they do not reflect the degree of activation of opioid re-
ceptors by the drug.10 Studies evaluating the site of action of epidu-
ral fentanyl have usually focused on the plasma concentration of the 
drug, its analgesic effect and the need for supplementary analgesia. 
However, a greater challenge would be to study the binding of this 
drug to its receptor.
The need for supplementary analgesia was greater in group 2 than 
in group 1. This finding suggests that epidural fentanyl is more effi-
cient than intravenous administration of the drug, as also reported in 
another study.12 Although the statistical analysis did not show any dif-
ference in the length of time before the first request for supplementary 
analgesia, analgesic supplementation occurred earlier in patients who 
had received intravenous fentanyl, thus suggesting that epidural fenta-
nyl has a longer-lasting effect. Another interesting point was that only 
two patients needed both types of analgesic supplements after epidural 
fentanyl while, after intravenous fentanyl, eight patients required both 
supplements. 
The intensity of pain was similar in the two groups, and this has also 
been reported in other studies.11,13,21 This finding shows that both intra-
venous and epidural fentanyl promoted good pain relief within the first 
30 minutes. However, after this period, part of the analgesic effect was 
mediated by supplementation. Other investigators also observed that, 
after the first hour, the pain was less intense after epidural fentanyl than 
after intravenous administration, despite the similar or even lower plas-
ma concentrations.
A correlation between plasma opioid concentration and pain relief 
has been reported.22-24 The minimum plasma fentanyl concentration for 
postoperative pain relief was 0.63 ng/ml.2
The plasma fentanyl concentrations observed at different times 
were similar to those reported in other studies.3,11,15,21 Some investiga-
tors found that the plasma concentration of fentanyl was much lower 
after epidural injection than after intravenous administration.12,16 
In the present study, only two patients in group 1 and one patient 
in group 2 presented a fentanyl concentration of 0.63 ng/ml during the 
period analyzed.
Another important point was that, in group 1, most patients pre-
sented good pain relief at T30, with plasma fentanyl concentrations low-
er than 0.63 ng/ml in the absence of any supplementary analgesia. In 
addition, many group 2 patients showed good pain relief despite a plas-
ma fentanyl concentration below the minimum required for analge-
sia, although the number of patients was smaller than in group 1. At 
T120, many group 1 patients still presented good pain relief with plasma 
fentanyl levels less than 0.63 ng/ml and did not require supplementa-
ry analgesics. In group 2, few patients presented adequate pain relief 
and all of them requested supplementary analgesia. After four hours, 
some group 1 patients continued to present good pain relief, although 
they did not receive any analgesic supplement, and their plasma fen-
tanyl concentration was less than 0.63 ng/ml. Four hours after epidu-
ral injection, the plasma fentanyl concentration was higher than after 
two hours, probably because it was spreading out from the distribution 
sites of the drug. 
The better analgesic effect of epidural fentanyl observed in the pres-
ent study, despite the lower plasma concentration of the drug, suggests 
that there is an effect caused by spinal action, in addition to the sys-
temic action. 
The side effects associated with fentanyl were nausea and vomiting. 
Urine retention, an adverse effect more frequently observed after epidu-
None Tenoxicam Bupivacaine
G1 G2 P G1 G2 P G1 G2 P
N (%) 10 (71) 8 (53) 0.4497* 3 (21) 3 (20) 1.0000* 1 (7) 5 (33) 0.1686*
NS 2.4 3.8 0.6965† 1.3 4.0 0.7000† 2.5 0.5 -
C (ng/ml) 0.3 0.2 0.1728† 0.2 0.1 1.0000† 0.2 0.3 -
Table 6. Cumulative number of applications of supplementary analgesic, pain intensity and plasma fentanyl concentrations among the patients, 240 
minutes after administration of epidural or intravenous fentanyl (T240)
NS = numerical scale; C = plasma fentanyl concentration; T240 = 240 minutes after administration of epidural or intravenous fentanyl;
 *Fisher’s exact test; †Mann-Whitney test
None Tenoxicam Bupivacaine
G1 G2 P G1 G2 P G1 G2 P
N (%) 13 (93) 15 (100) 0.4828* 1 (7) 0 (0) 0.4828 0 (0) 0 (0) -
NS 0.2 0.5 0.5186† 3.0 - - - - -
C (ng/ml) 0.4 0.3 0.6530† 0.3 - - - - -
Table 4. Cumulative number of applications of supplementary analgesic, pain intensity and plasma fentanyl concentrations among the patients, 30 
minutes after administration of epidural or intravenous fentanyl (T30)
NS = numerical scale; C = plasma fentanyl concentration; T30 = 30 minutes after administration of epidural or intravenous fentanyl; 
*Fisher’s exact test; †Mann-Whitney test
None Tenoxicam Bupivacaine
G1 G2 P G1 G2 P G1 G2 P
N (%) 8 (57) 3 (20) 0.0704* 6 (43) 12 (80) 0.0604* 1 (7) 3 (20) 0.5977*
NS 1.5 2.6 0.5196† 3.0 4.0 0.9999† 10 0.5 -
C (ng/ml) 0.2 0.2 0.3727† 0.2 0.2 0.4936† 0.26 0.3 -
Table 5. Cumulative number of applications of supplementary analgesic, pain intensity and plasma fentanyl concentrations among the patients, 120 
minutes after administration of epidural or intravenous fentanyl (T120)
NS = numerical scale; C = plasma fentanyl concentration; T120 = 120 minutes after administration of epidural or intravenous fentanyl; 
*Fisher’s exact test; †Mann-Whitney test
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ral opioids, was observed in the intravenous group. This effect was prob-
ably associated with the epidural bupivacaine used for anesthesia. 
CONCLUSION
Among patients undergoing lower-limb orthopedic surgery, intra-
venous and epidural fentanyl appear to have similar efficacy for reducing 
pain according to the numerical scale, but supplementary analgesia was 
needed less frequently when epidural fentanyl was used.
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